Menatrol
Menatrol is an FDA drug label for the active ingredient FOLATE, MULTIVITAMIN manufactured by PureTek Corporation administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231218.
Generic: FOLATE, MULTIVITAMIN
Manufacturer: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
Route: ORAL
Dosage Form:
NDC: 59088-156
Application:
Effective: 20231218
Indications & Usage
Indications and Usage: For the dietary management of menopausal symptoms and the support of overall health during the menopausal phase.
Dosage & Administration
Dosage and Administration: Take one (1) capsule daily or as directed by a licensed healthcare practitioner.
Contraindications
Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Menatrol™ Capsules are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
Warnings
Not available.
Adverse Reactions
Adverse Reactions: Possible side effects may include gastrointestinal upset. If any side effects persist or worsen, discontinue use and consult a physician.
More from same ingredient
No related products.